GlassScriptPhysician profile
Brian R Dix
NPI 1932215464
$1,080.45
in general payments reported to CMS, 2019-2025
17 companies · $109 in 2025
The $109 reported for 2025 was less than what a typical Pain Medicine (Anesthesiology) provider received nationally (typical 2025 total: $458).
See the full distribution for Pain Medicine (Anesthesiology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $72.52 · 2020: $61.22 · 2021: $158 · 2022: $392 · 2023: $287 · 2025: $109.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $396.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $396.06 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Teva Pharmaceuticals USA, INC. | $176.16 | 2021-2022 | |
| Boston Scientific Corporation | $103.64 | 2019-2023 | Wavewriter Alpha Prime 16 |
| Collegium Pharmaceutical, INC. | $95.69 | 2022-2023 | Belbuca, Xtampza |
| Idorsia Pharmaceuticals US INC | $91.64 | 2023 | Quviviq |
| Lilly USA, LLC | $82.87 | 2021-2023 | Emgality |
| Amgen INC. | $69.86 | 2022 | |
| Abbott Laboratories | $69.05 | 2021-2022 | |
| Medtronic, INC. | $67.30 | 2021-2023 | Intellis Adaptivestim |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $56.28 | 2022-2023 | Relistor |
| Biotronik Nro, INC. | $51.66 | 2025 | Prospera |
| Biodelivery Sciences International, INC. | $44.99 | 2021 | |
| Pfizer INC. | $37.75 | 2019-2021 | |
| Ambu INC. | $37.20 | 2025 | |
| Ibsa Pharma INC. | $33.60 | 2023 | Tirosint, Licart |
| Medtronic USA, INC. | $26.47 | 2019-2020 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Vertex Pharmaceuticals Incorporated | $20.43 | 2025 | |
| Daiichi Sankyo INC. | $15.86 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brian Dix listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.